Comparison of outcome for holmium laser enucleation prostate and Rezum system in benign prostate hyperplasia: a matched pair analysis - Summary - MDSpire
Advertisement
Comparison of outcome for holmium laser enucleation prostate and Rezum system in benign prostate hyperplasia: a matched pair analysis
To assess the efficacy and safety of Rezum therapy in patients with symptomatic BPH, particularly those with larger prostates, in comparison to HoLEP.
Key Findings:
Rezum effectively reduces LUTS and improves urinary flow metrics, with specific improvements noted in Qmax.
HoLEP is associated with a higher prevalence of retrograde ejaculation (65-90%), impacting patient quality of life.
Rezum shows potential for similar efficacy with fewer sexual side effects, as evidenced by lower rates of retrograde ejaculation.
Interpretation:
Both Rezum and HoLEP are effective for treating BPH, but Rezum may offer advantages in preserving sexual function, particularly for patients concerned about side effects.
Limitations:
Retrospective design may introduce bias, limiting the strength of causal inferences.
Limited generalizability due to specific patient population, which may not represent broader demographics.
Conclusion:
Rezum is a viable alternative to HoLEP for patients with BPH, particularly those concerned about sexual side effects.
